Understand the source comparison
Cagrilintide Real vs Fake — How to Tell | Real Peptides
Research published in the Journal of Pharmaceutical and Biomedical Analysis found that 47% of peptides purchased from unverified suppliers failed basic purity testing. Many contained no active compound whatsoever. When you're investing in cagrilintide for seri
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research published in the Journal of Pharmaceutical and Biomedical Analysis found that 47% of peptides purchased from unverified suppliers failed basic purity testing. Many contained no active compound whatsoever. When you're investing in cagrilintide for serious metabolic research, that statistic isn't academic. A counterfeit peptide doesn't just waste your money. It introduces bacterial endotoxins, heavy metal contamination, or complete absence of the amylin analogue you need.
- Our team at Real Peptides has guided researchers through this verification process across hundreds of orders. The gap between legitimate cagrilintide and a convincing fake comes down to three verification layers most suppliers never mention: certificate of analysis authenticity, molecular weight precision, and reconstitution behavior under sterile conditions.
- How can you verify if cagrilintide is authentic before using it in research?
- Authentic cagrilintide requires third-party certificate of analysis (COA) verification showing ≥98% purity via HPLC, precise molecular weight confirmation at 3,882.4 Da via mass spectrometry, and clear reconstitution in bacteriostatic water without precipitate formation. Counterfeit peptides fail one or more of these verification steps. Most commonly presenting fraudulent COAs, molecular weight deviations exceeding 0.5%, or visible particulate matter post-reconstitution indicating impure synthesis or bacterial contamination.
- The direct answer: legitimate cagrilintide demonstrates traceable batch-specific purity data, matches published molecular specifications exactly, and reconstitutes to optical clarity. The mechanism matters because cagrilintide's amylin receptor agonism depends on precise disulfide bridge formation during synthesis. Any deviation in the 37-amino-acid sequence or post-translational modification renders the compound biologically inactive. This article covers the three-layer verification protocol we apply to every batch, the specific red flags that indicate counterfeit product, and what reconstitution behavior reveals about peptide integrity before a single injection occurs.